Multivalent approaches and beyond

novel tools for the investigation of dopamine D2 receptor pharmacology

Research output: Contribution to journalReview ArticleResearchpeer-review

3 Citations (Scopus)

Abstract

The dopamine D2 receptor (D2R) has been implicated in the symptomology of disorders such as schizophrenia and Parkinson's disease. Multivalent ligands provide useful tools to investigate emerging concepts of G protein-coupled receptor drug action such as allostery, bitopic binding and receptor dimerization. This review focuses on the approaches taken toward the development of multivalent ligands for the D2R recently and highlights the challenges associated with each approach, their utility in probing D2R function and approaches to develop new D2R-targeting drugs. Furthermore, we extend our discussion to the possibility of designing multitarget ligands. The insights gained from such studies may provide the basis for improved therapeutic targeting of the D2R.

Original languageEnglish
Pages (from-to)1349-1372
Number of pages24
JournalFuture Medicinal Chemistry
Volume8
Issue number11
DOIs
Publication statusPublished - 1 Jul 2016

Keywords

  • allosteric
  • bitopic
  • bivalent
  • DR
  • designed multiple ligands
  • dopamine D receptor
  • multivalent
  • orthosteric

Cite this

@article{1910abb2b28c4a39a5d98e78c3d353f7,
title = "Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology",
abstract = "The dopamine D2 receptor (D2R) has been implicated in the symptomology of disorders such as schizophrenia and Parkinson's disease. Multivalent ligands provide useful tools to investigate emerging concepts of G protein-coupled receptor drug action such as allostery, bitopic binding and receptor dimerization. This review focuses on the approaches taken toward the development of multivalent ligands for the D2R recently and highlights the challenges associated with each approach, their utility in probing D2R function and approaches to develop new D2R-targeting drugs. Furthermore, we extend our discussion to the possibility of designing multitarget ligands. The insights gained from such studies may provide the basis for improved therapeutic targeting of the D2R.",
keywords = "allosteric, bitopic, bivalent, DR, designed multiple ligands, dopamine D receptor, multivalent, orthosteric",
author = "Anitha Kopinathan and Scammells, {Peter J.} and Lane, {J. Robert} and Ben Capuano",
year = "2016",
month = "7",
day = "1",
doi = "10.4155/fmc-2016-0010",
language = "English",
volume = "8",
pages = "1349--1372",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "11",

}

Multivalent approaches and beyond : novel tools for the investigation of dopamine D2 receptor pharmacology. / Kopinathan, Anitha; Scammells, Peter J.; Lane, J. Robert; Capuano, Ben.

In: Future Medicinal Chemistry, Vol. 8, No. 11, 01.07.2016, p. 1349-1372.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Multivalent approaches and beyond

T2 - novel tools for the investigation of dopamine D2 receptor pharmacology

AU - Kopinathan, Anitha

AU - Scammells, Peter J.

AU - Lane, J. Robert

AU - Capuano, Ben

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The dopamine D2 receptor (D2R) has been implicated in the symptomology of disorders such as schizophrenia and Parkinson's disease. Multivalent ligands provide useful tools to investigate emerging concepts of G protein-coupled receptor drug action such as allostery, bitopic binding and receptor dimerization. This review focuses on the approaches taken toward the development of multivalent ligands for the D2R recently and highlights the challenges associated with each approach, their utility in probing D2R function and approaches to develop new D2R-targeting drugs. Furthermore, we extend our discussion to the possibility of designing multitarget ligands. The insights gained from such studies may provide the basis for improved therapeutic targeting of the D2R.

AB - The dopamine D2 receptor (D2R) has been implicated in the symptomology of disorders such as schizophrenia and Parkinson's disease. Multivalent ligands provide useful tools to investigate emerging concepts of G protein-coupled receptor drug action such as allostery, bitopic binding and receptor dimerization. This review focuses on the approaches taken toward the development of multivalent ligands for the D2R recently and highlights the challenges associated with each approach, their utility in probing D2R function and approaches to develop new D2R-targeting drugs. Furthermore, we extend our discussion to the possibility of designing multitarget ligands. The insights gained from such studies may provide the basis for improved therapeutic targeting of the D2R.

KW - allosteric

KW - bitopic

KW - bivalent

KW - DR

KW - designed multiple ligands

KW - dopamine D receptor

KW - multivalent

KW - orthosteric

UR - http://www.scopus.com/inward/record.url?scp=84982949983&partnerID=8YFLogxK

U2 - 10.4155/fmc-2016-0010

DO - 10.4155/fmc-2016-0010

M3 - Review Article

VL - 8

SP - 1349

EP - 1372

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 11

ER -